Stocks Overview

LAST PRICE
13.4900
TODAY'S CHANGE (%)
0.0000 (0.0000%)

Bid / Lots
13.2400/ 11
Ask / Lots
13.6400/ 1
Open / Previous Close
--- / 13.4900
Day Range
---
52 Week Range
Low 12.5750
High 15.0800
Volume
---
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Friday's close: 13.38
Time	Volume	TAK
09:32 ET	43723	13.46
09:33 ET	200	13.46
09:35 ET	1996	13.455
09:37 ET	5572	13.475
09:39 ET	1502	13.485
09:42 ET	11507	13.495
09:44 ET	1018	13.495
09:46 ET	500	13.495
09:48 ET	1545	13.495
09:50 ET	1625	13.495
09:51 ET	1003	13.495
09:53 ET	348	13.49
09:55 ET	1831	13.49
09:57 ET	2591	13.494
10:00 ET	3190	13.495
10:02 ET	200	13.49
10:04 ET	3686	13.485
10:06 ET	2229	13.475
10:08 ET	2018	13.475
10:09 ET	5036	13.485
10:11 ET	6624	13.465
10:13 ET	2625	13.465
10:15 ET	2542	13.465
10:18 ET	27759	13.485
10:20 ET	1156	13.485
10:22 ET	3284	13.485
10:24 ET	2198	13.48
10:26 ET	2121	13.4891
10:27 ET	13563	13.49
10:29 ET	1305	13.495
10:31 ET	3424	13.495
10:33 ET	4174	13.49
10:36 ET	2548	13.495
10:38 ET	2560	13.49
10:40 ET	3465	13.495
10:42 ET	6191	13.485
10:44 ET	8787	13.475
10:45 ET	2256	13.47
10:47 ET	7857	13.475
10:49 ET	1436	13.475
10:51 ET	3661	13.47
10:54 ET	4041	13.46
10:56 ET	6531	13.46
10:58 ET	2119	13.45
11:00 ET	2958	13.455
11:02 ET	1228	13.45
11:03 ET	2324	13.45
11:05 ET	1919	13.45
11:07 ET	6497	13.46
11:09 ET	1809	13.45
11:12 ET	3762	13.46
11:14 ET	4531	13.455
11:16 ET	1869	13.45
11:18 ET	7891	13.46
11:20 ET	22897	13.46
11:21 ET	10708	13.47
11:23 ET	3229	13.46
11:25 ET	12116	13.46
11:27 ET	9478	13.45
11:30 ET	9192	13.46
11:32 ET	1307	13.46
11:34 ET	1976	13.46
11:36 ET	938	13.46
11:38 ET	6506	13.455
11:39 ET	36288	13.435
11:41 ET	2550	13.4313
11:43 ET	2370	13.435
11:45 ET	3072	13.43
11:48 ET	1683	13.435
11:50 ET	10823	13.44
11:52 ET	5803	13.43
11:54 ET	10932	13.435
11:56 ET	9351	13.435
11:57 ET	5550	13.44
11:59 ET	4881	13.4339
12:01 ET	11246	13.435
12:03 ET	5039	13.44
12:06 ET	21994	13.445
12:08 ET	3653	13.45
12:10 ET	3696	13.45
12:12 ET	9363	13.46
12:14 ET	2107	13.455
12:15 ET	2323	13.455
12:17 ET	13142	13.445
12:19 ET	6052	13.45
12:21 ET	10942	13.445
12:24 ET	4900	13.445
12:26 ET	3630	13.45
12:28 ET	8430	13.445
12:30 ET	15540	13.44
12:32 ET	1032	13.435
12:33 ET	1300	13.435
12:35 ET	1388	13.435
12:37 ET	8321	13.435
12:39 ET	1441	13.44
12:42 ET	3017	13.435
12:44 ET	1557	13.435
12:46 ET	2205	13.43
12:48 ET	3461	13.4339
12:50 ET	5198	13.435
12:51 ET	10553	13.44
12:53 ET	4482	13.43
12:55 ET	4229	13.44
12:57 ET	27235	13.445
01:00 ET	8478	13.445
01:02 ET	4012	13.45
01:04 ET	17632	13.455
01:06 ET	3996	13.46
01:08 ET	4913	13.455
01:09 ET	1957	13.455
01:11 ET	5504	13.455
01:13 ET	1491	13.455
01:15 ET	1394	13.455
01:18 ET	1500	13.455
01:20 ET	2944	13.455
01:22 ET	13970	13.45
01:24 ET	6923	13.455
01:26 ET	7554	13.455
01:27 ET	6730	13.455
01:29 ET	5797	13.455
01:31 ET	5181	13.455
01:33 ET	11293	13.465
01:36 ET	3359	13.47
01:38 ET	3087	13.465
01:40 ET	4471	13.465
01:42 ET	7228	13.475
01:44 ET	19064	13.465
01:45 ET	1829	13.46
01:47 ET	2327	13.46
01:49 ET	4601	13.465
01:51 ET	2014	13.465
01:54 ET	1372	13.465
01:56 ET	3160	13.47
01:58 ET	9112	13.47
02:00 ET	10760	13.47
02:02 ET	1826	13.465
02:03 ET	3136	13.47
02:05 ET	4726	13.465
02:07 ET	1544	13.465
02:09 ET	4611	13.465
02:12 ET	7726	13.47
02:14 ET	297	13.475
02:16 ET	1067	13.475
02:18 ET	2397	13.48
02:20 ET	1005	13.48
02:21 ET	2404	13.4799
02:23 ET	11907	13.48
02:25 ET	11117	13.475
02:27 ET	8079	13.47
02:30 ET	10128	13.475
02:32 ET	7507	13.475
02:34 ET	2665	13.47
02:36 ET	9906	13.47
02:38 ET	6131	13.475
02:39 ET	7778	13.4799
02:41 ET	2603	13.475
02:43 ET	3359	13.475
02:45 ET	2533	13.475
02:48 ET	1908	13.475
02:50 ET	3442	13.475
02:52 ET	3693	13.48
02:54 ET	2484	13.475
02:56 ET	2580	13.47
02:57 ET	2911	13.47
02:59 ET	7338	13.475
03:01 ET	4951	13.475
03:03 ET	1805	13.48
03:06 ET	1791	13.475
03:08 ET	2407	13.475
03:10 ET	1703	13.4788
03:12 ET	13070	13.49
03:14 ET	7583	13.495
03:15 ET	2782	13.5
03:17 ET	3856	13.495
03:19 ET	17285	13.4885
03:21 ET	248	13.485
03:24 ET	8542	13.485
03:26 ET	5634	13.4894
03:28 ET	1616	13.485
03:30 ET	6757	13.4801
03:32 ET	3027	13.49
03:33 ET	3097	13.49
03:35 ET	4719	13.49
03:37 ET	5535	13.49
03:39 ET	3915	13.49
03:42 ET	9630	13.49
03:44 ET	7150	13.5
03:46 ET	6480	13.5
03:48 ET	5728	13.5
03:50 ET	23290	13.51
03:51 ET	90605	13.495
03:53 ET	17582	13.495
03:55 ET	4677	13.5
03:57 ET	11156	13.5
04:00 ET	214206	13.49

Data delayed at least 15 minutes.

Nov 21, 2024
- HUTCHMED Announces Launch by Takeda of FRUZAQLA(R) (fruquintinib) in Japan, from 11:30PM ET on Thursday Nov 21, 2024 by Dow Jones
  11:30PM ET on Thursday Nov 21, 2024 by Dow Jones
Nov 4, 2024
- New Survey Data Highlights the Importance of Prioritizing Mental Health for Canadians Living with IBD, from 8:01AM ET on Monday Nov 04, 2024 by Dow Jones
  8:01AM ET on Monday Nov 04, 2024 by Dow Jones
Oct 31, 2024
- HUTCHMED to Receive First Commercial Milestone Payment Following Over US$200 Million in FRUZAQLA(R) (fruquintinib) Sales by Takeda, from 4:30AM ET on Thursday Oct 31, 2024 by Dow Jones
  4:30AM ET on Thursday Oct 31, 2024 by Dow Jones
- Press Release: HUTCHMED to Receive First Commercial Milestone Payment Following Over US$200 Million in FRUZAQLA(R) (fruquintinib) Sales by Takeda, from 4:30AM ET on Thursday Oct 31, 2024 by Dow Jones
  4:30AM ET on Thursday Oct 31, 2024 by Dow Jones
- DJ Takeda Pharmaceutical Posts Quarterly Net Profit, Raises Guidance -- Update, from 3:12AM ET on Thursday Oct 31, 2024 by Dow Jones
  3:12AM ET on Thursday Oct 31, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesTAK Takeda Pharmaceutical Co Ltd	42.7B	22.9x	-8.01%
United StatesLFVN LifeVantage Corp	177.9M	43.3x	-14.53%
United StatesBVNRY Bavarian Nordic A/S	2.2B	13.7x	---
United StatesXERS Xeris Biopharma Holdings Inc	460.7M	-7.0x	---
United StatesLFCR Lifecore Biomedical Inc	269.2M	201.9x	+27.97%
United StatesASRT Assertio Holdings Inc	89.8M	-1.4x	---
As of 2024-11-26

Takeda Pharmaceutical Company Limited is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the research, development, manufacture and sale of pharmaceutical products, General medical products, quasi drugs and healthcare products in Japan and overseas. The Company's research and development functions are concentrated in four areas of oncology (cancer), digestive system diseases, rare diseases and neurology (neuropsychiatric diseases), as well as two business units of plasma fractionation products and vaccines. The Company is engaged in the improvement of pipelines at research and development centers located mainly in Japan and the United States.

Contact Information

Headquarters: 4F, 2-1-1, Nihombashihon-choCHUO-KU, TKY, Japan 103-8668
Phone: ---
Fax: ---

Executives

Chairman of Board of Directors, Independent Director: Masami Iijima
President, Chief Executive Officer, Representative Director: Christophe Weber
Chief Financial Officer, Director: Milano Furuta
President of Research & Development, Director: Andrew Plump
Independent Director: Jean-Luc Butel

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$42.7B
Revenue (TTM)	$29.5B
Shares Outstanding	3.2B
Dividend Yield	2.17%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	0.54
EPS	$0.59
Book Value	$15.03
P/E Ratio	22.9x
Price/Sales (TTM)	1.4
Price/Cash Flow (TTM)	6.3x
Operating Margin	9.80%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Takeda Pharmaceutical Co Ltd
NYSE:TAKUnited States

Search Criteria

Charts

Recent News

Nov 21, 2024

HUTCHMED Announces Launch by Takeda of FRUZAQLA(R) (fruquintinib) in Japan, from 11:30PM ET on Thursday Nov 21, 2024 by Dow Jones

Nov 4, 2024

New Survey Data Highlights the Importance of Prioritizing Mental Health for Canadians Living with IBD, from 8:01AM ET on Monday Nov 04, 2024 by Dow Jones

Oct 31, 2024

HUTCHMED to Receive First Commercial Milestone Payment Following Over US$200 Million in FRUZAQLA(R) (fruquintinib) Sales by Takeda, from 4:30AM ET on Thursday Oct 31, 2024 by Dow Jones

Press Release: HUTCHMED to Receive First Commercial Milestone Payment Following Over US$200 Million in FRUZAQLA(R) (fruquintinib) Sales by Takeda, from 4:30AM ET on Thursday Oct 31, 2024 by Dow Jones

DJ Takeda Pharmaceutical Posts Quarterly Net Profit, Raises Guidance -- Update, from 3:12AM ET on Thursday Oct 31, 2024 by Dow Jones

Pharmaceuticals - Diversified Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar